The role of non-drug methods of increasing adherence to the treatment of patients with arterial hypertension in a polyclinic

Introduction. Arterial hypertension (AH) is one of the important high-risk factors for the development of heart diseases, but its diagnosis and treatment does not require high technologies and substantial costs. However, the asymptomatic course of AH combined with a low level of medical literacy contributes to low adherence to treatment.

Aim. To study the indirect impact of remote blood pressure monitoring (RBPM), the introduction of educational materials (EMs) in comparison with self-monitoring of blood pressure (SMBP) on adherence of patients with AH to outpatient treatment.

Materials and methods. 60 subjects with an established fact of partial or complete refusal to use antihypertensive therapy were enrolled in the study and randomized into four equal and comparable groups: 1 – SMBP, 2 – RBPM, 3 – SMBP + EMs, 4 – RBPM + EMs. The impact of using RBPM was assessed by comparing blood pressure values in groups 1 and 2; the impact of EM – by comparing the results of questionnaire surveys in groups 1 and 2 and groups 3 and 4.

Results and discussion. Additional training of patients with AH contributed to a twofold increase in adherence in using SCAD and RBPM. The average systolic blood pressure in groups 1 and 2 was 134 mm Hg, in groups 3 and 4 – 129 mm Hg; diastolic blood pressure in groups 1 and 2 – 78.5 mm Hg, in groups 3 and 4 – 77.5 mm Hg.

Conclusion. The maximum impact on adherence to AH treatment can be achieved with the introduction of a set of measures. However, the introduction of RBPM has a number of limitations associated with the additional economic burden and the lack of an approved methodology. However, the provision of treatment and prevention facilities with EMs does not require additional development of methodology and is significantly cheaper than the cost of modern blood pressure monitors.

1. Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. https://doi.org/10.1093/eurheartj/ehw106.

2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. https://doi.org/10.1016/S0140-6736(21)01330-1.

3. Lim S.S., Vos T., Flaxman A.D., Danaei G., Shibuya K., Adair-Rohani H. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859): 2224–2260. https://doi.org/10.1016/S0140-6736(12)61766-8.

4. Piera-Jiménez J., Winters M., Broers E., Valero-Bover D., Habibovic M., Widdershoven J.W.M.G. et al. Changing the Health Behavior of Patients With Cardiovascular Disease Through an Electronic Health Intervention in Three Different Countries: Cost-Effectiveness Study in the Do Cardiac Health: Advanced New Generation Ecosystem (Do CHANGE) 2 Randomized Controlled Trial. J Med Internet Res. 2020;22(7):e17351. https://doi.org/10.2196/17351.

5. Erina A.M., Rotar O.P., Solntsev V.N., Shalnova S.A., Deev A.D., Baranova E.I. et al. Epidemiology of Arterial Hypertension in Russian Federation – Importance of Choice of Criteria of Diagnosis. Kardiologiya. 2019;59(6):5–11. (In Russ.) https://doi.org/10.18087/cardio.2019.6.2595.

6. Agaeva A., Kuznetsova V., Dubov A., Svirina E., Tuchkova A., Melekhov A. et al. Arterial hypertension and antihypertensive treatment in unorganized Moscow population. J Hypertens. 2019;37(1):e164. https://doi.org/10.1097/01.hjh.0000572104.13418.60.

7. Krousel-Wood M.A., Muntner P., Islam T., Morisky D.E., Webber L.S. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am. 2009;93(3):753–769. https://doi.org/10.1016/j.mcna.2009.02.007.

8. Da Silva Lima D.B., Magalhães Moreira T.M., Pereira Borges J.W., Pacheco Rodrigues M.T. Association between treatment compliance and different types of cardiovascular complications in arterial hypertension patients. Texto Contexto Enferm. 2016;25(3):e0560015. https://doi.org/10.1590/0104-07072016000560015.

9. Boytsov S.A., Balanova Yu.A., Shalnova S.A., Deev A.D., Artamonova G.V., Gatagonova T.M. et al. arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2014;13(4):4–14. (In Russ.) https://doi.org/10.15829/1728-8800-2014-4-4-14.

10. Campbell N.R., Brant R., Johansen H., Walker R.L., Wielgosz A., Onysko J. et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension. 2009;53(2):128–134. https://doi.org/10.1161/HYPERTENSIONAHA.108.119784.

11. Márquez Contreras E., Márquez Rivero S., Rodríguez García E., Baldonedo Suárez A. ¿Cómo evaluar y mejorar la adherencia en la consulta diaria? Hipertens Riesgo Vasc. 2017;34(1 Suppl.):29–35. https://doi.org/10.1016/S1889-1837(18)30061-8.

12. Paczkowska A., Kopciuch D., Nowakowska E., Hoffmann K., Bryl W. Compliance Among Adolescents with Arterial Hypertension. Adv Clin Exp Med. 2016;25(3):441–448. https://doi.org/10.17219/acem/33838.

13. Girotto E., de Andrade S.M., Cabrera M.A., Matsuo T. Adesão ao tratamento farmacológico e não farmacológico e fatores associados na atenção primária da hipertensão arterial. Cien Saude Colet. 2013;18(6):1763–1772. https://doi.org/10.1590/S1413-81232013000600027.

14. Riegel B., Moser D.K., Buck H.G., Dickson V.V., Dunbar S.B., Lee C.S. et al. Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association. J Am Heart Assoc. 2017;6(9):e006997. https://doi.org/10.1161/JAHA.117.006997.

15. Sarycheva A.А., Nebieridze D.V., Kamyshova T.V. Is it possible to improve the adherence to treatment of hypertension and dyslipidemia in patients without clinical manifestations of atherosclerosis? Ratsional’naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology. 2017;13(5):602–608. (In Russ.) https://doi.org/10.20996/1819-6446-2017-13-5-602-608.

16. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349): 1903–1913. https://doi.org/10.1016/s0140-6736(02)11911-8.

17. Gorbunov V.M. Home blood pressure monitoring in modern clinical practice. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2010;9(6):121–135. (In Russ.) Available at: https://cardiovascular.elpub.ru/jour/article/view/2154/0.

18. Iancu M.A., Mateiciuc I.I., Stanescu A.A., Matei D., Diaconu C.C. Therapeutic Compliance of Patients with Arterial Hypertension in Primary Care. Medicina (Kaunas). 2020;56(11):631. https://doi.org/10.3390/medicina56110631.

19. Moltu C., Stefansen J., Svisdahl M., Veseth M. Negotiating the coresearcher mandate – service users’ experiences of doing collaborative research on mental health. Disabil Rehabil. 2012;34(19):1608–1616. https://doi.org/10.3109/09638288.2012.656792.

20. Márquez Contreras E., Martel Claros N., Gil Guillén V., Martín De Pablos J.L., De la Figuera Von Wichman M., Casado Martínez J.J. et al. Intervención no farmacológica como estrategia para favorecer el control de la hipertensión arterial y mejorar el cumplimiento antihipertensivo. Aten Primaria. 2009;41(9):501–510. https://doi.org/10.1016/j.aprim.2009.02.004.

21. Lee M.H., Park Y.H. The effectiveness of the information-motivation-behavioral skills model-based intervention on preventive behaviors against respiratory infection among community-dwelling older adults. Patient Educ Couns. 2021;104(8):2028–2036. https://doi.org/10.1016/j.pec.2021.01.016.

22. Parati G., Dolan E., McManus R.J., Omboni S. Home blood pressure telemonitoring in the 21st century. J Clin Hypertens (Greenwich). 2018;20(7):1128–1132. https://doi.org/10.1111/jch.13305.

23. Parati G., Omboni S., Albini F., Piantoni L., Giuliano A., Revera M. et al. Home blood ressure telemonitoring improves hypertension control in general practice. The TeleBPCare study. J Hypertens. 2009;27(1):198–203. https://doi.org/10.1097/hjh.0b013e3283163caf.

24. Parati G., Stergiou G.S., Asmar R., Bilo G., de Leeuw P., Imai Y. et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26(8):1505–1526. https://doi.org/10.1097/HJH.0b013e328308da66.

25. Pickering T.G., Miller N.H., Ogedegbe G., Krakoff L.R., Artinian N.T., Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):10–29. https://doi.org/10.1161/HYPERTENSIONAHA.107.189010.

26. Stergiou G., Mengden T., Padfield P.L., Parati G., O’Brien E. Self monitoring of blood pressure at home. BMJ. 2004;329(7471):870–871. https://doi.org/10.1136/bmj.329.7471.870.

27. O’Brien E., Asmar R., Beilin L., Imai Y., Mallion J.M., Mancia G. et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21(5):821–848. https://doi.org/10.1097/00004872-200305000-00001.

28. Cappuccio F.P., Kerry S.M., Forbes L., Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004;329(7458):145. https://doi.org/10.1136/bmj.38121.684410.AE.

29. Liyanage-Don N., Fung D., Phillips E., Kronish I.M. Implementing Home Blood Pressure Monitoring into Clinical Practice. Curr Hypertens Rep. 2019;21(2):14. https://doi.org/10.1007/s11906-019-0916-0.

30. Gutiérrez-Angulo M.L., Lopetegi-Uranga P., Sánchez-Martín I., Garaigordobil-Landazabal M. Cumplimiento terapéutico en pacientes con hipertensión arterial y diabetes mellitus 2. Rev Calid Asist. 2012;27(2):72–77. https://doi.org/10.1016/j.cali.2011.09.008.

31. Kobalava Z.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I. et al. Arterial hypertension in adults. Clinical guidelines 2020. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.) https://doi.org/10.15829/1560-4071-2020-3-3786.

32. Denolle T. Recommandations sur la mesure de la pression artérielle. Consensus d’experts de la Société française d’hypertension artérielle, filiale de la Société française de cardiologie. Presse Med. 2019;48(11 Pt 1):1319–1328. https://doi.org/10.1016/j.lpm.2019.09.060.

33. Myers M.G. Reporting bias in self-measurement of blood pressure. Blood Press Monit. 2001;6(4):181–183. https://doi.org/10.1097/00126097-200108000-00003.

34. Mengden T., Hernandez Medina R.M., Beltran B., Alvarez E., Kraft K., Vetter H. Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens. 1998;11(12):1413–1417. https://doi.org/10.1016/s0895-7061(98)00241-6.

35. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21(6):1011–1053. https://doi.org/10.1097/00004872-200306000-00001.

36. Gamzaev M.A. The importance of blood pressure self-control in increasing patient adherence to the treatment of arterial hypertension. Meditsinskiy vestnik Bashkortostana = Medical Bulletin of Bashkortostan. 2013;8(1):46–49. (In Russ.) Available at: https://www.mvb-bsmu.ru/files/journals/1_2013.pdf.